UBS raised the firm’s price target on Charles River (CRL) to $250 from $240 and keeps a Buy rating on the shares post the earnings ...
Charles River Labs Q3 revenue of $1.01 billion surpassed expectations; however, revenue declined 1.6% YoY, and operating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback